Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01410838 · ClinicalTrials.gov registry record · NA
Effects of Monosodium Glutamate on Energy Balance and Eating Behavior
A NA study, sponsored by USDA, Western Human Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01410838 is a NA study that has completed, run by USDA, Western Human Nutrition Research Center. The registered enrollment target is 44 participants.
The verdict
NCT01410838, a NA study, has completed, sponsored by USDA, Western Human Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study will test whether regular consumption of Monosodium Glutamate (MSG) immediately prior to each of the three major meals (breakfast, lunch, dinner) inhibits body weight and fat regain following a period of moderate, yet clinically significant weight loss.
Interventions
- OTHER Broth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01410838
The ClinicalTrials.gov registry entry for NCT01410838 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is USDA, Western Human Nutrition Research Center, which has 47 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Broth is the first listed.
NCT01410838 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01410838 about?
NCT01410838 is a clinical study titled "Effects of Monosodium Glutamate on Energy Balance and Eating Behavior". This study will test whether regular consumption of Monosodium Glutamate (MSG) immediately prior to each of the three major meals (breakfast, lunch, dinner) inhibits body weight and fat regain following a period of moderate, yet clinically significant weight loss.
What is the current status of trial NCT01410838?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2011-08. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01410838?
The interventions under investigation include: Broth (OTHER).
Who is sponsoring clinical trial NCT01410838?
This trial is sponsored by USDA, Western Human Nutrition Research Center, which has 47 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.